SQZ Biotechnologies Co (SQZB)
0.021
0.00 (0.00%)
USD |
OTCM |
May 17, 15:23
SQZ Biotechnologies Shareholders Equity (Quarterly): 24.54M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 24.54M |
| March 31, 2023 | 40.16M |
| December 31, 2022 | 57.15M |
| September 30, 2022 | 68.57M |
| June 30, 2022 | 88.19M |
| March 31, 2022 | 104.91M |
| December 31, 2021 | 123.98M |
| Date | Value |
|---|---|
| September 30, 2021 | 133.21M |
| June 30, 2021 | 152.70M |
| March 31, 2021 | 169.28M |
| December 31, 2020 | 127.20M |
| September 30, 2020 | -104.16M |
| June 30, 2020 | 81.79M |
| December 31, 2019 | -73.52M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-104.16M
Minimum
Sep 2020
169.28M
Maximum
Mar 2021
71.00M
Average
84.99M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 54.15M |
| Total Liabilities (Quarterly) | 29.61M |
| Current Ratio | 2.793 |